{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:59:50Z","timestamp":1787619590010,"version":"build-2736575974"},"reference-count":16,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2020,1,7]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>In 2017, almost 4000 Canadians died from opioid-related causes. Coadministration of opioids and benzodiazepines is a risk factor for overdose. Few studies have evaluated leveraging pharmacists to address opioid-benzodiazepine coprescribing. Our aim was to develop and test a role for pharmacists as opioid stewards, to reduce opioid and benzodiazepine doses in coprescribed patients. We conducted Plan-Do-Study-Act cycles between November 2017 and May 2018 across two primary care centre clinics. A third clinic acted as a control. Our intervention included a pharmacist: (1) identifying patients through medical record queries; (2) developing care plans; (3) discussing recommendations with physicians and (4) discussing implementing recommendations. We refined the intervention according to patient and physician feedback. At the intervention clinics, the number of patients with pharmacist developed care plans increased from less than 20% at baseline to over 60% postintervention. There was also a fourfold increase in the number of patients with an active opioid taper. At the control clinic, the number of patients with pharmacist developed care plans remained relatively stable at less than 20%. The number of patients with active opioid tapers remained zero. At the intervention clinics, mean daily opioid dose decreased 11% from 50.5 milligrams morphine equivalent (MME) to 44.7 MME. At the control clinic, it increased 15% from 62.3 MME to 71.4 MME. The number of patients with a benzodiazepine taper remained relatively stable at both the intervention and control clinics at less than 20%. At the intervention clinics, mean daily benzodiazepine dose decreased 8% from 9.9 milligrams diazepam equivalent (MDE) to 9.3 MDE. At the control clinic, it decreased 4% from 10.8 MDE to 10.4 MDE. A proactive, pharmacist-led intervention for coprescribed patients increased opioid tapers and decreased opioid and benzodiazepine doses. Future work will help us understand whether sustaining the intervention ultimately reduces rates of opioid-benzodiazepine coprescribing.<\/jats:p>","DOI":"10.1136\/bmjoq-2019-000635","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:15:51Z","timestamp":1586315751000},"page":"e000635","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4927-514X","authenticated-orcid":false,"given":"Tiana","family":"Tilli","sequence":"first","affiliation":[{"name":"Pharmacy Department, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hunchuck","sequence":"additional","affiliation":[{"name":"Pharmacy Department, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Dewhurst","sequence":"additional","affiliation":[{"name":"Pharmacy Department, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-112X","authenticated-orcid":false,"given":"Tara","family":"Kiran","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada"},{"name":"Quality Business Unit, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"2025083110275261000_9.2.e000635.1","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"2025083110275261000_9.2.e000635.2","unstructured":"Canadian Institute for Health Information . Pan-Canadian trends in the prescribing of opioids, 2012 to 2016. Ottawa: CIHI, 2017."},{"key":"2025083110275261000_9.2.e000635.3","doi-asserted-by":"crossref","unstructured":"Busse J . The 2017 Canadian guideline for opioids for chronic non-cancer pain. Hamilton, ON, 2017.","DOI":"10.1503\/cmaj.733313"},{"key":"2025083110275261000_9.2.e000635.4","unstructured":"Health Quality Ontario . Opioid prescribing for chronic pain: care for people 15 years of age and older: Queen\u2019s Printer for Ontario. Toronto, ON: Queen\u2019s Printer for Ontario, 2018."},{"key":"2025083110275261000_9.2.e000635.5","unstructured":"Ontario Ministry of Health and Long-Term Care . Family health teams [Internet], 2016. Available: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/fht\/ [Accessed Nov 2019]."},{"key":"2025083110275261000_9.2.e000635.6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/08897077.2016.1179242","article-title":"The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain","volume":"37","author":"Park","year":"2016","journal-title":"Subst Abus"},{"key":"2025083110275261000_9.2.e000635.7","first-page":"356","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"14","author":"Sun","year":"2016","journal-title":"BMJ"},{"key":"2025083110275261000_9.2.e000635.8","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013515001"},{"key":"2025083110275261000_9.2.e000635.9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among Medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Med Care"},{"key":"2025083110275261000_9.2.e000635.10","doi-asserted-by":"crossref","unstructured":"Gomes T , Greaves S , Martin D , et al . Latest trends in opioid-related deaths in Ontario: 1991 to 2015. Ontario Drug Policy Research Network, 2017.","DOI":"10.31027\/ODPRN.2017.01"},{"key":"2025083110275261000_9.2.e000635.11","unstructured":"Sinai Health System-University Health Network Antimicrobial Stewardship Program . SHS-UHN ASP guiding principles [Internet], 2017. Available: http:\/\/www.antimicrobialstewardship.com\/shs-uhn-asp-guiding-principles [Accessed Nov 2017]."},{"key":"2025083110275261000_9.2.e000635.12","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1093\/cid\/ciu542","article-title":"Core elements of hospital antibiotic stewardship programs from the centers for disease control and prevention","volume":"59(Suppl 3)","author":"Pollack","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025083110275261000_9.2.e000635.13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/acem.13273","article-title":"Emergency department provider perspectives on benzodiazepine-opioid coprescribing: a qualitative study","volume":"25","author":"Kim","year":"2018","journal-title":"Acad Emerg Med"},{"key":"2025083110275261000_9.2.e000635.14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08897077.2017.1290011","article-title":"Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a veteran population","volume":"38","author":"Pardo","year":"2017","journal-title":"Subst Abus"},{"key":"2025083110275261000_9.2.e000635.15","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp161032"},{"key":"2025083110275261000_9.2.e000635.16","first-page":"1257","article-title":"Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population","volume":"57","author":"Kahan","year":"2011","journal-title":"Can Fam Physician"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2019-000635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:28:07Z","timestamp":1756661287000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2019-000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,4,7]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/bmjoq-2019-000635"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2019-000635","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}